Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 327
interventional 267
Observational 54
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 63
Behavioral 25
Biological|Drug|Other 18
Other 18
Biological|Other 17
Device 17
Biological 14
Biological|Drug 10
Drug|Other 10
Drug|placebo 9
Procedure 8
Behavioral|Other 6
Drug|Other|Procedure 5
Drug|Procedure 5
Biological|Drug|Procedure 4
Biological|Procedure 3
Dietary Supplement 3
Drug|Radiation 3
Behavioral|Device 2
Biological|Drug|Other|Procedure 2
Drug|Other|placebo 2
Genetic 2
Other|Procedure 2
Behavioral|Other|Procedure 1
Biological|Drug|placebo 1
Biological|Drug|Radiation 1
Biological|Other|placebo 1
Biological|Other|Procedure 1
Combination Product 1
Device|Diagnostic Test|Other 1
Device|Drug 1
Device|Other 1
Device|Procedure 1
Diagnostic Test 1
Dietary Supplement|placebo 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Procedure 1
Drug|Other|Procedure|Radiation 1
Other|Radiation 1
Procedure|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 190
NA 10
United Kingdom 7
Australia 5
France 5
Canada 4
United States|Canada 4
Denmark 3
Netherlands 3
Austria 2
Belgium 2
China 2
Italy 2
Norway 2
Switzerland 2
United States|Australia 2
United States|Puerto Rico 2
Australia|New Zealand 1
Belgium|Hungary 1
Brazil 1
Cuba 1
Denmark|Germany|Norway|Sweden|United Kingdom 1
Egypt|Saudi Arabia 1
France|Germany|Spain 1
France|Germany|Switzerland 1
Ireland 1
Israel 1
Sweden 1
Turkey 1
United States|Australia|Belgium|France|Germany|Israel|Italy|Netherlands|New Zealand|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Canada|Czechia|France|Germany|Greece|Ireland|Italy|Japan|Netherlands|New Zealand|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Canada|New Zealand 1
United States|Australia|Canada|Sweden|United Kingdom 1
United States|Australia|Sweden|United Kingdom 1
United States|Canada|Ireland 1
United States|France 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 178
2 22
3 9
4 6
5 4
6 4
7 3
8 1
9 3
10 1
11 2
12 2
13 4
15 1
16 1
19 2
20 1
21 3
23 2
25 2
63 1
84 1
102 1
148 1
219 1
258 1
281 1
308 1
489 1
583 1
638 1
748 1
760 1
802 1
950 1
1329 1

Phase

Phase Study_Count
Phase 2 85
N/A 84
Phase 1 43
Phase 3 21
Phase 1/Phase 2 17
Early Phase 1 8
Phase 4 7
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 99
2 101
3 19
4 18
5 3
6 2
8 2
9 1
37 1
NA 21

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.000 10.0000 4.00000 5.00000 1.0000 98.00 72.00 6.0000
1st Qu. 10.000 60.0000 20.00000 23.00000 22.5000 162.75 130.25 22.5000
Median 13.000 130.0000 30.00000 41.00000 45.0000 227.50 430.00 50.0000
Mean 20.625 802.9639 40.11905 86.23529 163.1899 227.50 1113.10 220.1429
3rd Qu. 20.750 482.5000 44.75000 75.00000 91.0000 292.25 900.00 243.0000
Max. 70.000 14381.0000 233.00000 352.00000 6452.0000 357.00 10250.00 954.0000

Trial Group Type

group_type Group_Count
Experimental 378
Active Comparator 71
No Intervention 26
Placebo Comparator 24
NA 21
Other 20

Intervention Model

intervention_model Study_Count
Parallel Assignment 133
Single Group Assignment 109
NA 13
Sequential Assignment 5
Factorial Assignment 4
Crossover Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 171
Prevention 52
Supportive Care 14
Diagnostic 12
Other 4
Screening 4
NA 4
Health Services Research 3
Basic Science 2
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 37
Germany 3
NA 3
United Kingdom 3
France 2
Austria 1
Belgium 1
Canada 1
Israel 1
Sweden 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 47
2 5
3 1
4 1

Enrollment Metrics

Measure Observational
Min 7.00
1st Qu 59.00
Median 250.00
Mean 19958.25
3rd Qu 840.00
Max 1000000.00

Observation Model

observational_model Study_Count
Cohort 23
Case-Only 9
Case-Control 8
Other 5
NA 4
Case Control 2
Case-Crossover 1
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 31
Retrospective 9
Cross-Sectional 7
NA 4
Other 3

Registries

Studies by Country

Country Study_Count
United States 2
Austria 1
NA 1
Spain 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 3
4 1
6 1
15 1

Enrollment Metrics

Measure Registries
Min 500.00
1st Qu 2125.00
Median 4500.00
Mean 31704.83
3rd Qu 5750.00
Max 173229.00

Registry Model

observational_model Study_Count
Cohort 5
Other 1

Time Perspective

time_perspective Study_Count
Prospective 5
Other 1

Follow-up

target_duration Study_Count
10 Years 2
1 Year 1
30 Years 1
36 Months 1
4 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT01134614 Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01134614 Active, not recruiting National Cancer Institute (NCI) 2013-02-15
NCT03543969 Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma https://ClinicalTrials.gov/show/NCT03543969 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2021-09-30
NCT03425461 Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma https://ClinicalTrials.gov/show/NCT03425461 Active, not recruiting University of Utah 2020-12-01
NCT03396952 Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma https://ClinicalTrials.gov/show/NCT03396952 Recruiting University of California, San Francisco 2022-06-07
NCT04273061 Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity https://ClinicalTrials.gov/show/NCT04273061 Recruiting British Columbia Cancer Agency 2024-10-31
NCT03329846 An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma https://ClinicalTrials.gov/show/NCT03329846 Active, not recruiting Bristol-Myers Squibb 2020-07-31
NCT03325101 Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery https://ClinicalTrials.gov/show/NCT03325101 Recruiting Mayo Clinic 2022-10-31
NCT03315286 Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure https://ClinicalTrials.gov/show/NCT03315286 Completed Weill Medical College of Cornell University 2019-01-31
NCT03313492 Modifying Young Adult Skin Cancer Risk and Protective Behaviors https://ClinicalTrials.gov/show/NCT03313492 Active, not recruiting Rutgers, The State University of New Jersey 2019-07-31
NCT03291002 Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC https://ClinicalTrials.gov/show/NCT03291002 Recruiting CureVac AG 2022-10-31
NCT03281161 Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention https://ClinicalTrials.gov/show/NCT03281161 Completed Klein Buendel, Inc. 2017-04-30
NCT03278340 Using Technology to Scale-Up an Occupational Sun Protection Policy Program https://ClinicalTrials.gov/show/NCT03278340 Enrolling by invitation Klein Buendel, Inc. 2022-06-30
NCT03276832 Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma https://ClinicalTrials.gov/show/NCT03276832 Recruiting Mayo Clinic 2021-02-15
NCT03246412 Nevus Doctor Clinical Decision Support for GPs https://ClinicalTrials.gov/show/NCT03246412 Recruiting University Hospital of North Norway 2020-12-31
NCT03243929 Translation of District Sun Safe Policies to Schools https://ClinicalTrials.gov/show/NCT03243929 Completed Claremont Graduate University 2018-03-21
NCT03237013 Strategies to Promote Skin Health https://ClinicalTrials.gov/show/NCT03237013 Completed San Diego State University 2016-12-14
NCT03229278 Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma https://ClinicalTrials.gov/show/NCT03229278 Active, not recruiting Rutgers, The State University of New Jersey 2022-07-30
NCT03201120 Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing https://ClinicalTrials.gov/show/NCT03201120 Completed University of Pennsylvania 2017-09-28
NCT03199911 Topical Antibiotic Prophylaxis for Eyelids https://ClinicalTrials.gov/show/NCT03199911 Recruiting University of California, San Francisco 2020-04-30
NCT03175432 Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases https://ClinicalTrials.gov/show/NCT03175432 Recruiting M.D. Anderson Cancer Center 2021-06-30
NCT03154190 Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer https://ClinicalTrials.gov/show/NCT03154190 Recruiting Stanford University 2020-11-30
NCT03132012 Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection https://ClinicalTrials.gov/show/NCT03132012 Completed Yale University 2018-02-27
NCT03131908 Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss https://ClinicalTrials.gov/show/NCT03131908 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT03131713 Preoperative Acetaminophen and Carbohydrate Loading https://ClinicalTrials.gov/show/NCT03131713 Completed Tufts Medical Center 2017-12-31
NCT03112668 Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners https://ClinicalTrials.gov/show/NCT03112668 Completed Rutgers, The State University of New Jersey 2018-01-25
NCT03101358 Study of Topical SOR007 Ointment for Cutaneous Metastases https://ClinicalTrials.gov/show/NCT03101358 Active, not recruiting NanOlogy, LLC 2020-05-31
NCT03093909 Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases https://ClinicalTrials.gov/show/NCT03093909 Recruiting M.D. Anderson Cancer Center 2021-11-30
NCT03079232 Optical Coherence Microscopy in Dermato-oncology https://ClinicalTrials.gov/show/NCT03079232 Completed Centre Hospitalier Universitaire de Saint Etienne 2018-08-01
NCT03071406 Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma https://ClinicalTrials.gov/show/NCT03071406 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2023-07-31
NCT03057327 Promoting Early Detection of Melanoma During the Mammography Experience https://ClinicalTrials.gov/show/NCT03057327 Completed Northwestern University 2017-07-27
NCT03025256 Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease https://ClinicalTrials.gov/show/NCT03025256 Recruiting M.D. Anderson Cancer Center 2020-12-30
NCT03021460 Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT03021460 Recruiting Mayo Clinic 2021-02-01
NCT03012581 Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types https://ClinicalTrials.gov/show/NCT03012581 Recruiting UNICANCER 2023-01-31
NCT03012009 Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT03012009 Completed University Hospital, Ghent 2017-05-31
NCT02978625 Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers https://ClinicalTrials.gov/show/NCT02978625 Recruiting National Cancer Institute (NCI) 2021-06-01
NCT02971709 Use of Shade in U.S. and Australian City Parks https://ClinicalTrials.gov/show/NCT02971709 Completed Klein Buendel, Inc. 2017-05-31
NCT02941744 A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases https://ClinicalTrials.gov/show/NCT02941744 Completed Universitair Ziekenhuis Brussel 2018-12-31
NCT02902822 Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo https://ClinicalTrials.gov/show/NCT02902822 Completed Centro Studi Gised 2019-05-31
NCT02897765 A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer https://ClinicalTrials.gov/show/NCT02897765 Completed Neon Therapeutics, Inc. 2020-02-29
NCT02872909 Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer https://ClinicalTrials.gov/show/NCT02872909 Completed University of Dundee 2017-02-06
NCT02857374 Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy https://ClinicalTrials.gov/show/NCT02857374 Completed Roswell Park Cancer Institute 2018-08-28
NCT02836548 HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma https://ClinicalTrials.gov/show/NCT02836548 Recruiting The Netherlands Cancer Institute 2019-06-30
NCT02835807 Engaging Moms on Teen Indoor Tanning Through Social Media https://ClinicalTrials.gov/show/NCT02835807 Recruiting Klein Buendel, Inc. 2021-01-31
NCT02824289 Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers https://ClinicalTrials.gov/show/NCT02824289 Completed Klein Buendel, Inc. 2015-04-30
NCT02816021 Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT02816021 Recruiting M.D. Anderson Cancer Center 2025-02-28
NCT02780934 Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction https://ClinicalTrials.gov/show/NCT02780934 Completed Dartmouth-Hitchcock Medical Center 2016-05-31
NCT02760160 Dietary Prevention of Photodamage in Skin With Grapes https://ClinicalTrials.gov/show/NCT02760160 Completed University of Alabama at Birmingham 2018-09-27
NCT02751151 Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT02751151 Recruiting Inova Health Care Services 2020-02-29
NCT02748564 Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma https://ClinicalTrials.gov/show/NCT02748564 Active, not recruiting Rutgers, The State University of New Jersey 2021-06-30
NCT02721459 XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma https://ClinicalTrials.gov/show/NCT02721459 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-10-31
NCT02705352 5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts https://ClinicalTrials.gov/show/NCT02705352 Completed Massachusetts Eye and Ear Infirmary 2019-01-25
NCT02704104 Safety and Performance Evaluation of the Topical Hemostatic Device (AC5â„¢) Following Excision of Skin Lesions https://ClinicalTrials.gov/show/NCT02704104 Completed ARCH Therapuetics 2016-06-30
NCT02668614 Early Detection of Skin Cancer With Sensor Technology https://ClinicalTrials.gov/show/NCT02668614 Completed Lawson Health Research Institute 2018-02-28
NCT02652455 Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma https://ClinicalTrials.gov/show/NCT02652455 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-08-30
NCT02636569 Topical Chemoprevention of Skin Cancer Biomarkers https://ClinicalTrials.gov/show/NCT02636569 Recruiting University of Alabama at Birmingham 2021-03-31
NCT03033576 Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma https://ClinicalTrials.gov/show/NCT03033576 Recruiting National Cancer Institute (NCI) 2022-03-15
NCT02650986 Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 https://ClinicalTrials.gov/show/NCT02650986 Recruiting Roswell Park Cancer Institute 2021-06-20
NCT02224781 Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma https://ClinicalTrials.gov/show/NCT02224781 Recruiting National Cancer Institute (NCI) 2022-10-02
NCT01940809 Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01940809 Active, not recruiting National Cancer Institute (NCI) 2020-12-31
NCT03028948 Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma https://ClinicalTrials.gov/show/NCT03028948 Active, not recruiting Rutgers, The State University of New Jersey 2021-01-31
NCT02910700 Nivolumab and Trametinib With or Without Dabrafenib in Treating Patients With BRAF Mutated or Wild Type Metastatic Stage III-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02910700 Recruiting M.D. Anderson Cancer Center 2021-12-31
NCT02595866 Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms https://ClinicalTrials.gov/show/NCT02595866 Recruiting National Cancer Institute (NCI) 2021-07-01
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT02465060 Recruiting National Cancer Institute (NCI) 2022-06-30
NCT01989572 Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery https://ClinicalTrials.gov/show/NCT01989572 Completed National Cancer Institute (NCI) 2012-10-08
NCT01950390 Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01950390 Active, not recruiting National Cancer Institute (NCI) 2021-07-01
NCT01480154 Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer https://ClinicalTrials.gov/show/NCT01480154 Active, not recruiting National Cancer Institute (NCI) 2020-02-14
NCT02550678 A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT02550678 Completed Ascend Biopharmaceuticals Ltd 2017-11-30
NCT02519322 Neoadjuvant and Adjuvant Checkpoint Blockade https://ClinicalTrials.gov/show/NCT02519322 Recruiting M.D. Anderson Cancer Center 2020-08-01
NCT02500576 Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT02500576 Active, not recruiting M.D. Anderson Cancer Center 2020-08-31
NCT02423863 In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® https://ClinicalTrials.gov/show/NCT02423863 Recruiting Oncovir, Inc. 2021-06-30
NCT02409628 EktoTherixâ„¢ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds https://ClinicalTrials.gov/show/NCT02409628 Completed Neotherix Limited 2017-07-31
NCT02385214 MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT02385214 Active, not recruiting Melanoma and Skin Cancer Trials Limited 2026-08-05
NCT02373722 Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery https://ClinicalTrials.gov/show/NCT02373722 Completed Wake Forest University Health Sciences 2016-03-31
NCT02352428 Skin Cancer Screening Education Study https://ClinicalTrials.gov/show/NCT02352428 Active, not recruiting Association of Dermatological Prevention, Germany 2018-12-31
NCT02324608 Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer https://ClinicalTrials.gov/show/NCT02324608 Recruiting Rutgers, The State University of New Jersey 2020-11-30
NCT02320305 MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT02320305 Completed Mayo Clinic 2015-12-07
NCT02304458 Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas https://ClinicalTrials.gov/show/NCT02304458 Active, not recruiting National Cancer Institute (NCI) 2021-01-31
NCT02298959 Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02298959 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT02248584 VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE https://ClinicalTrials.gov/show/NCT02248584 Completed University of Campinas, Brazil 2011-12-31
NCT02231775 Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation https://ClinicalTrials.gov/show/NCT02231775 Recruiting M.D. Anderson Cancer Center 2022-10-31
NCT02196181 Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02196181 Active, not recruiting National Cancer Institute (NCI) 2020-12-31
NCT02192918 Pilot Investigation of Behavioral Alternatives to Indoor Tanning https://ClinicalTrials.gov/show/NCT02192918 Completed University of Massachusetts, Worcester 2015-04-30
NCT02166996 A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck https://ClinicalTrials.gov/show/NCT02166996 Completed Sundsvall Hospital 2013-01-31
NCT02147080 A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults https://ClinicalTrials.gov/show/NCT02147080 Completed Fox Chase Cancer Center 2014-10-31
NCT03384836 Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT03384836 Recruiting Roswell Park Cancer Institute 2020-10-11
NCT02130297 Post Excision/Mohs Scar Laser Resurfacing https://ClinicalTrials.gov/show/NCT02130297 Completed Icahn School of Medicine at Mount Sinai 2019-03-19
NCT02129075 CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV Melanoma https://ClinicalTrials.gov/show/NCT02129075 Active, not recruiting National Cancer Institute (NCI) 2016-03-28
NCT02125058 Intracutaneous Versus Transcutaneous Sutures in the Face (IC vs TC Sutures) https://ClinicalTrials.gov/show/NCT02125058 Completed Maastricht University Medical Center 2016-04-30
NCT02097875 Safety Study of a Fluorescent Marker to Visualize Cancer Cells https://ClinicalTrials.gov/show/NCT02097875 Completed Blaze Bioscience Australia Pty Ltd 2015-03-31
NCT02097225 Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02097225 Active, not recruiting National Cancer Institute (NCI) 2019-03-31
NCT01303341 Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma https://ClinicalTrials.gov/show/NCT01303341 Active, not recruiting National Cancer Institute (NCI) 2018-04-16
NCT01292668 Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer https://ClinicalTrials.gov/show/NCT01292668 Completed Roswell Park Cancer Institute 2012-07-31
NCT01274338 Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT01274338 Active, not recruiting National Cancer Institute (NCI) 2019-02-15
NCT02046811 Reducing Skin Cancer Risk in Childhood Cancer Survivors https://ClinicalTrials.gov/show/NCT02046811 Completed Harvard School of Public Health 2018-01-01
NCT02036476 Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma https://ClinicalTrials.gov/show/NCT02036476 Active, not recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02032810 Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma https://ClinicalTrials.gov/show/NCT02032810 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2017-09-06
NCT02965716 Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma https://ClinicalTrials.gov/show/NCT02965716 Recruiting National Cancer Institute (NCI) 2020-06-30
NCT01989559 Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery https://ClinicalTrials.gov/show/NCT01989559 Completed National Cancer Institute (NCI) 2013-09-30
NCT01973322 Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized “Proof-of-principle” Phase II Study https://ClinicalTrials.gov/show/NCT01973322 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2020-08-31
NCT01961115 Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma https://ClinicalTrials.gov/show/NCT01961115 Completed Fred Hutchinson Cancer Research Center 2016-10-31
NCT01955460 Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma https://ClinicalTrials.gov/show/NCT01955460 Recruiting M.D. Anderson Cancer Center 2020-10-31
NCT01941901 Calcium Electroporation for Treatment of Cutaneous Metastases https://ClinicalTrials.gov/show/NCT01941901 Completed Herlev Hospital 2016-09-30
NCT01886235 Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery https://ClinicalTrials.gov/show/NCT01886235 Active, not recruiting Roswell Park Cancer Institute 2015-06-16
NCT01861496 Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours https://ClinicalTrials.gov/show/NCT01861496 Recruiting Oncology Venture 2020-09-30
NCT01835626 Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01835626 Completed University of California, San Francisco 2019-09-10
NCT01820234 Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event https://ClinicalTrials.gov/show/NCT01820234 Completed University of California, Davis 2011-06-30
NCT01807182 Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT01807182 Active, not recruiting Fred Hutchinson Cancer Research Center 2020-06-30
NCT01804595 A Randomized Control Trial of Sun Protection Interventions for Operating Engineers https://ClinicalTrials.gov/show/NCT01804595 Completed University of Michigan 2013-12-31
NCT01791894 Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01791894 Completed Stanford University 2013-11-30
NCT04204837 Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin https://ClinicalTrials.gov/show/NCT04204837 Recruiting Salzburger Landeskliniken 2021-03-31
NCT01748448 Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome https://ClinicalTrials.gov/show/NCT01748448 Recruiting Universitaire Ziekenhuizen Leuven 2023-09-30
NCT01740557 Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma https://ClinicalTrials.gov/show/NCT01740557 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT01738139 Ipilimumab and Imatinib Mesylate in Advanced Cancer https://ClinicalTrials.gov/show/NCT01738139 Recruiting M.D. Anderson Cancer Center 2022-02-28
NCT01727076 Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01727076 Completed National Cancer Institute (NCI) 2016-06-30
NCT01708941 Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01708941 Active, not recruiting National Cancer Institute (NCI) 2017-08-08
NCT01693068 Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT01693068 Completed EMD Serono 2015-07-04
NCT01644591 Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases https://ClinicalTrials.gov/show/NCT01644591 Recruiting M.D. Anderson Cancer Center 2020-08-31
NCT01638533 Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction https://ClinicalTrials.gov/show/NCT01638533 Active, not recruiting National Cancer Institute (NCI) 2018-11-29
NCT01526486 Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer https://ClinicalTrials.gov/show/NCT01526486 Completed Emory University 2013-02-28
NCT01522820 Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors https://ClinicalTrials.gov/show/NCT01522820 Completed Roswell Park Cancer Institute 2016-07-31
NCT01508013 An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk https://ClinicalTrials.gov/show/NCT01508013 Completed East Tennessee State University 2014-05-31
NCT01482104 New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) https://ClinicalTrials.gov/show/NCT01482104 Completed Norwegian University of Science and Technology 2017-10-31
NCT01464957 Skin Cancer Prevention in a Pediatric Population https://ClinicalTrials.gov/show/NCT01464957 Completed University of Colorado, Denver 2007-09-30
NCT01463709 Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer https://ClinicalTrials.gov/show/NCT01463709 Completed UCSF Benioff Children’s Hospital Oakland 2012-06-30
NCT01460875 Recombinant Interferon Alfa-2b in Treating Patients With Melanoma https://ClinicalTrials.gov/show/NCT01460875 Completed Ohio State University Comprehensive Cancer Center 2014-01-05
NCT01458002 Online Tailored Interventions & Relational Agents for Exercise and Sun Protection https://ClinicalTrials.gov/show/NCT01458002 Completed University of Rhode Island 2013-05-31
NCT01447355 Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation https://ClinicalTrials.gov/show/NCT01447355 Completed National Cancer Institute (NCI) 2012-10-31
NCT01359735 Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients https://ClinicalTrials.gov/show/NCT01359735 Completed Healthpoint 2011-11-30
NCT01356771 Melanoma Risk Assessment & Tailored Intervention https://ClinicalTrials.gov/show/NCT01356771 Completed University of Pennsylvania 2016-02-29
NCT01319565 Prospective Randomized Study of Cell Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor Infiltrating Lymphocytes Plus IL-2 Following Either a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Alone or in Conjunction w/1200 TBI https://ClinicalTrials.gov/show/NCT01319565 Active, not recruiting National Institutes of Health Clinical Center (CC) 2024-06-01
NCT01989585 Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01989585 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT04377360 Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors https://ClinicalTrials.gov/show/NCT04377360 Recruiting Alpha Tau Medical LTD. 2021-06-30
NCT04341064 Sun-safe Habits Intervention and Education https://ClinicalTrials.gov/show/NCT04341064 Recruiting University of Utah 2025-02-28
NCT04310397 Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma https://ClinicalTrials.gov/show/NCT04310397 Recruiting M.D. Anderson Cancer Center 2022-02-28
NCT04251598 I am Protecting my Child From the Sun Program https://ClinicalTrials.gov/show/NCT04251598 Completed Akdeniz University 2018-06-15
NCT04176237 School-based Randomized Trial of SunSmart Interventions https://ClinicalTrials.gov/show/NCT04176237 Completed University of Southern California 2017-01-10
NCT04163419 Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis https://ClinicalTrials.gov/show/NCT04163419 Active, not recruiting Massachusetts General Hospital 2023-06-30
NCT04138342 Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer https://ClinicalTrials.gov/show/NCT04138342 Recruiting Al-Azhar University 2021-06-14
NCT04112342 Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry https://ClinicalTrials.gov/show/NCT04112342 Enrolling by invitation West Virginia University 2020-05-21
NCT04059588 A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin https://ClinicalTrials.gov/show/NCT04059588 Recruiting Rockefeller University 2021-07-31
NCT04056962 Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma https://ClinicalTrials.gov/show/NCT04056962 Recruiting West China Hospital 2021-08-30
NCT04040114 Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI) https://ClinicalTrials.gov/show/NCT04040114 Recruiting Melanoma and Skin Cancer Trials Limited 2020-10-31
NCT04036344 Buddy Relationships in DermatoloGic Excisions for Skin Cancer https://ClinicalTrials.gov/show/NCT04036344 Completed Abramson Cancer Center of the University of Pennsylvania 2019-08-27
NCT04007744 Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04007744 Recruiting Mayo Clinic 2021-07-31
NCT03979872 Risk Information and Skin-cancer Education for Undergraduate Prevention https://ClinicalTrials.gov/show/NCT03979872 Enrolling by invitation University of Utah 2021-05-15
NCT03944941 Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT03944941 Recruiting Alliance for Clinical Trials in Oncology 2022-12-31
NCT03906253 Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia https://ClinicalTrials.gov/show/NCT03906253 Recruiting Wright State Physicians 2025-12-31
NCT03901573 High-Risk Skin Cancers With Atezolizumab Plus NT-I7 https://ClinicalTrials.gov/show/NCT03901573 Recruiting NeoImmuneTech 2024-02-29
NCT03873818 Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain https://ClinicalTrials.gov/show/NCT03873818 Active, not recruiting M.D. Anderson Cancer Center 2020-05-01
NCT03865212 Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma https://ClinicalTrials.gov/show/NCT03865212 Recruiting Mayo Clinic 2021-03-15
NCT03860883 Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT03860883 Recruiting Melanoma and Skin Cancer Trials Limited 2029-12-31
NCT03858855 Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment https://ClinicalTrials.gov/show/NCT03858855 Completed Ohio State University Comprehensive Cancer Center 2020-04-13
NCT03816332 Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers https://ClinicalTrials.gov/show/NCT03816332 Recruiting National Cancer Institute (NCI) 2021-05-30
NCT03769285 Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial https://ClinicalTrials.gov/show/NCT03769285 Recruiting Women’s College Hospital 2020-12-31
NCT03769155 VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma https://ClinicalTrials.gov/show/NCT03769155 Recruiting Emory University 2021-12-31
NCT03767660 Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation https://ClinicalTrials.gov/show/NCT03767660 Recruiting Peking Union Medical College Hospital 2022-01-01
NCT03767348 Study of RP1 Monotherapy and RP1 in Combination With Nivolumab https://ClinicalTrials.gov/show/NCT03767348 Recruiting Replimune Inc. 2021-11-30
NCT03754140 Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases https://ClinicalTrials.gov/show/NCT03754140 Recruiting Melanoma Institute Australia 2021-05-31
NCT03752736 Sun Safety Skills for Elementary School Students https://ClinicalTrials.gov/show/NCT03752736 Completed Stanford University 2019-04-11
NCT03740815 Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection https://ClinicalTrials.gov/show/NCT03740815 Recruiting Instituto Nacional de Cancer, Brazil 2019-07-31
NCT03737734 Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) https://ClinicalTrials.gov/show/NCT03737734 Recruiting Alpha Tau Medical LTD. 2020-12-31
NCT03731247 Optical Coherence Microscopy in Dermato-oncology https://ClinicalTrials.gov/show/NCT03731247 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-09-30
NCT03727789 CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma https://ClinicalTrials.gov/show/NCT03727789 Recruiting Roswell Park Cancer Institute 2021-08-08
NCT03716193 Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry https://ClinicalTrials.gov/show/NCT03716193 Recruiting West Virginia University 2020-06-01
NCT03714828 Study of TVEC in Patients With Cutaneous Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT03714828 Recruiting University of Arizona 2021-03-01
NCT03677739 Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families https://ClinicalTrials.gov/show/NCT03677739 Recruiting Rutgers, The State University of New Jersey 2023-06-01
NCT03673917 Cosmetology Students and Skin Cancer https://ClinicalTrials.gov/show/NCT03673917 Completed University of Arkansas 2017-06-30
NCT03655756 pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT03655756 Recruiting Morphogenesis, Inc. 2020-08-31
NCT03607578 Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations https://ClinicalTrials.gov/show/NCT03607578 Completed Danish Cancer Society 2019-01-11
NCT03590054 A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies https://ClinicalTrials.gov/show/NCT03590054 Recruiting University of California, San Francisco 2022-02-15
NCT03564769 Evaluation Study of SPOTme® Skin Cancer Screenings https://ClinicalTrials.gov/show/NCT03564769 Completed Harvard School of Public Health 2018-10-01
NCT03554083 Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma https://ClinicalTrials.gov/show/NCT03554083 Recruiting Mayo Clinic 2023-06-29
NCT03541148 Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT03541148 Completed Catalysis SL 2016-04-13
NCT03534947 A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma https://ClinicalTrials.gov/show/NCT03534947 Recruiting Melanoma Institute Australia 2020-12-31
NCT03458117 T-VEC in Non-melanoma Skin Cancer https://ClinicalTrials.gov/show/NCT03458117 Recruiting University of Zurich 2020-02-29
NCT03430934 Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor https://ClinicalTrials.gov/show/NCT03430934 Recruiting University of Missouri-Columbia 2020-12-01
NCT03420963 Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors https://ClinicalTrials.gov/show/NCT03420963 Recruiting M.D. Anderson Cancer Center 2022-12-01
NCT03419637 Mobile Devices as Educational Skin History Tools https://ClinicalTrials.gov/show/NCT03419637 Completed University of Pennsylvania 2017-08-02
NCT01258855 Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01258855 Completed National Cancer Institute (NCI) 2018-03-29
NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT01155258 Completed University of Southern California 2013-01-31
NCT01131234 Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT01131234 Completed National Cancer Institute (NCI) 2014-09-30
NCT01118091 Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M… https://ClinicalTrials.gov/show/NCT01118091 Completed National Institutes of Health Clinical Center (CC) 2012-04-30
NCT01108094 Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas https://ClinicalTrials.gov/show/NCT01108094 Completed Stanford University 2011-03-31
NCT01053819 Can We Miss Pigmented Lesions in Psoriasis Patients? https://ClinicalTrials.gov/show/NCT01053819 Completed University of Alabama at Birmingham 2012-04-30
NCT01032343 An Immunonutritional Approach to the Prevention of Skin Cancer https://ClinicalTrials.gov/show/NCT01032343 Completed University of Manchester 2010-07-31
NCT01032031 The Effect of Green Tea and Vitamin C on Skin Health https://ClinicalTrials.gov/show/NCT01032031 Completed University of Manchester 2012-08-31
NCT00993512 Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer https://ClinicalTrials.gov/show/NCT00993512 Completed PCI Biotech AS 2011-05-31
NCT00923195 Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00923195 Completed National Institutes of Health Clinical Center (CC) 2011-08-31
NCT00894855 Skin Cancer Screening and Education at Beaches https://ClinicalTrials.gov/show/NCT00894855 Completed Dana-Farber Cancer Institute 2008-11-30
NCT00885534 Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00885534 Completed Memorial Sloan Kettering Cancer Center 2013-10-31
NCT00866177 MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma https://ClinicalTrials.gov/show/NCT00866177 Completed National Cancer Institute (NCI) 2013-09-30
NCT00862901 Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma https://ClinicalTrials.gov/show/NCT00862901 Completed Tufts Medical Center 2011-01-31
NCT00859768 The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients https://ClinicalTrials.gov/show/NCT00859768 Completed Netherlands Open University 2010-10-31
NCT00847912 CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial https://ClinicalTrials.gov/show/NCT00847912 Completed VA Office of Research and Development 2013-06-28
NCT03719131 Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy https://ClinicalTrials.gov/show/NCT03719131 Recruiting Emory University 2021-10-31
NCT00826306 Comparison Of Video-based Versus Written Patient Education on Sunscreen https://ClinicalTrials.gov/show/NCT00826306 Completed University of California, Davis 2009-08-31
NCT04127318 Low-moderate Intensity Pedaling During Immunotherapy Administration https://ClinicalTrials.gov/show/NCT04127318 Enrolling by invitation Rush University Medical Center 2020-10-31
NCT03509467 Using MC1R Genotype to Impact Melanoma Risk Behavior https://ClinicalTrials.gov/show/NCT03509467 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-11-30
NCT03245788 Effectiveness of Lay Navigators in Meeting Cancer Patients’ Non-Clinical Needs: A Pilot Study https://ClinicalTrials.gov/show/NCT03245788 Completed Stanford University 2018-07-31
NCT01631331 Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) https://ClinicalTrials.gov/show/NCT01631331 Completed Stanford University 2015-09-17
NCT00804908 A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00804908 Completed AbbVie 2016-01-31
NCT01130519 A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer https://ClinicalTrials.gov/show/NCT01130519 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-01
NCT03096548 Sun Safety Ink! A Sun Safety Program for the Tattoo Community https://ClinicalTrials.gov/show/NCT03096548 Recruiting Klein Buendel, Inc. 2021-01-01
NCT02580916 Utility of the Skin Cancer Quality of Life Impact Tool https://ClinicalTrials.gov/show/NCT02580916 Completed Oxford University Hospitals NHS Trust 2017-08-31
NCT02581930 Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma https://ClinicalTrials.gov/show/NCT02581930 Active, not recruiting National Cancer Institute (NCI) 2018-02-10
NCT03698019 A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma https://ClinicalTrials.gov/show/NCT03698019 Recruiting National Cancer Institute (NCI) 2022-09-01
NCT02506153 High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT02506153 Active, not recruiting National Cancer Institute (NCI) 2023-09-15
NCT00785369 In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis https://ClinicalTrials.gov/show/NCT00785369 Completed Lucid, Inc. 2009-12-31
NCT00784108 Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry. https://ClinicalTrials.gov/show/NCT00784108 Completed University of California, Irvine 2012-09-30
NCT00765193 The Impact of Total Body Skin Examination on Skin Cancer Detection https://ClinicalTrials.gov/show/NCT00765193 Completed Medical University of Graz 2009-05-31
NCT00709306 The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention https://ClinicalTrials.gov/show/NCT00709306 Completed Fox Chase Cancer Center 2008-06-30
NCT00705887 A Motivational Enhancement Approach to Skin Cancer Prevention https://ClinicalTrials.gov/show/NCT00705887 Completed Oregon Health and Science University 2007-06-30
NCT00665470 Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma https://ClinicalTrials.gov/show/NCT00665470 Completed National Institutes of Health Clinical Center (CC) 2012-04-30
NCT00655655 Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00655655 Completed Mayo Clinic 2009-09-15
NCT00644384 Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer https://ClinicalTrials.gov/show/NCT00644384 Completed Mayo Clinic 2006-05-31
NCT00601640 Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin https://ClinicalTrials.gov/show/NCT00601640 Completed University of Arizona 2010-02-28
NCT00588341 Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection https://ClinicalTrials.gov/show/NCT00588341 Completed Memorial Sloan Kettering Cancer Center 2009-03-31
NCT00578214 Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery https://ClinicalTrials.gov/show/NCT00578214 Completed Mayo Clinic 2008-04-30
NCT00563290 Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00563290 Completed National Cancer Institute (NCI) 2012-04-30
NCT00535769 Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use https://ClinicalTrials.gov/show/NCT00535769 Completed Massachusetts General Hospital 2007-11-30
NCT00520299 Study of ADI-PEG 20 in Patients With Advanced Melanoma https://ClinicalTrials.gov/show/NCT00520299 Completed Ludwig Institute for Cancer Research 2010-03-31
NCT00509288 Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes https://ClinicalTrials.gov/show/NCT00509288 Completed National Institutes of Health Clinical Center (CC) 2011-07-31
NCT00492895 Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients https://ClinicalTrials.gov/show/NCT00492895 Completed University of Zurich 2010-12-31
NCT00472459 PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer https://ClinicalTrials.gov/show/NCT00472459 Completed Galderma NA
NCT00433485 Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants https://ClinicalTrials.gov/show/NCT00433485 Completed Yale University 2008-03-31
NCT00432471 Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers https://ClinicalTrials.gov/show/NCT00432471 Completed M.D. Anderson Cancer Center 2017-06-25
NCT00403377 Investigation of a Behavioral Substitute for Sunbathing https://ClinicalTrials.gov/show/NCT00403377 Completed University of Massachusetts, Worcester 2007-12-31
NCT00397982 Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma https://ClinicalTrials.gov/show/NCT00397982 Completed National Cancer Institute (NCI) 2013-07-31
NCT00387751 Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma https://ClinicalTrials.gov/show/NCT00387751 Completed National Cancer Institute (NCI) 2009-09-30
NCT00367042 Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks https://ClinicalTrials.gov/show/NCT00367042 Completed University of California, Davis 2006-07-31
NCT00346021 Sun Protection for Florida’s Children https://ClinicalTrials.gov/show/NCT00346021 Completed University of South Florida 2011-08-31
NCT00295958 LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00295958 Completed National Institutes of Health Clinical Center (CC) 2006-06-30
NCT00224744 Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage https://ClinicalTrials.gov/show/NCT00224744 Completed Institut Claudius Regaud 2013-01-31
NCT00204789 Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT00204789 Completed University of Wisconsin, Madison 2007-12-31
NCT00193895 Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck https://ClinicalTrials.gov/show/NCT00193895 Completed Trans-Tasman Radiation Oncology Group (TROG) 2016-03-31
NCT00189332 Use of 852A in Metastatic Cutaneous Melanoma. https://ClinicalTrials.gov/show/NCT00189332 Completed Pfizer 2006-08-31
NCT00133887 TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT00133887 Completed Hospices Civils de Lyon 2011-03-31
NCT00129961 Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT00129961 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-01-31
NCT00126555 Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer https://ClinicalTrials.gov/show/NCT00126555 Completed National Cancer Institute (NCI) 2013-02-28
NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00110019 Completed National Cancer Institute (NCI) 2011-01-31
NCT00103246 Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen’s Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides https://ClinicalTrials.gov/show/NCT00103246 Completed Case Comprehensive Cancer Center 2008-12-31
NCT00094107 Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00094107 Completed Pfizer 2008-04-30
NCT00089180 T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant https://ClinicalTrials.gov/show/NCT00089180 Completed National Cancer Institute (NCI) 2007-01-31
NCT00005884 Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer https://ClinicalTrials.gov/show/NCT00005884 Completed University of Wisconsin, Madison 2000-12-31
NCT00002506 Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer https://ClinicalTrials.gov/show/NCT00002506 Completed Hoag Memorial Hospital Presbyterian 1996-01-31
NCT00003549 S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer https://ClinicalTrials.gov/show/NCT00003549 Completed Southwest Oncology Group 2001-09-30
NCT00083252 Study of Talabostat and Cisplatin in Advanced Melanoma https://ClinicalTrials.gov/show/NCT00083252 Completed Point Therapeutics NA
NCT00083239 Study of Talabostat in Advanced Melanoma https://ClinicalTrials.gov/show/NCT00083239 Completed Point Therapeutics NA
NCT00079300 Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer https://ClinicalTrials.gov/show/NCT00079300 Completed National Institutes of Health Clinical Center (CC) NA
NCT00079131 Oblimersen in Treating Patients With Merkel Cell Carcinoma https://ClinicalTrials.gov/show/NCT00079131 Completed National Cancer Institute (NCI) 2007-01-31
NCT00025012 Isotretinoin in Preventing Skin Cancer https://ClinicalTrials.gov/show/NCT00025012 Completed National Cancer Institute (NCI) NA
NCT00021294 Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis https://ClinicalTrials.gov/show/NCT00021294 Completed University of Arizona 2002-06-30
NCT00068783 S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer https://ClinicalTrials.gov/show/NCT00068783 Completed National Cancer Institute (NCI) 2007-06-30
NCT00066872 Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer https://ClinicalTrials.gov/show/NCT00066872 Completed National Cancer Institute (NCI) NA
NCT00006361 SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck https://ClinicalTrials.gov/show/NCT00006361 Completed National Cancer Institute (NCI) 2003-01-31
NCT00054691 ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin https://ClinicalTrials.gov/show/NCT00054691 Completed M.D. Anderson Cancer Center 2012-10-31
NCT00027586 Imatinib Mesylate in Treating Patients With Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00027586 Completed M.D. Anderson Cancer Center 2005-01-31
NCT00023621 Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome https://ClinicalTrials.gov/show/NCT00023621 Completed National Cancer Institute (NCI) NA
NCT00021125 Radiation Therapy in Treating Patients With Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00021125 Completed National Cancer Institute (NCI) NA
NCT00019682 Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00019682 Completed National Cancer Institute (NCI) 2011-05-31
NCT00017485 Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer https://ClinicalTrials.gov/show/NCT00017485 Completed Roswell Park Cancer Institute 2006-12-31
NCT00003611 Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation https://ClinicalTrials.gov/show/NCT00003611 Completed Alliance for Clinical Trials in Oncology 2003-02-28
NCT00002975 Photodynamic Therapy in Treating Patients With Skin Cancer https://ClinicalTrials.gov/show/NCT00002975 Completed Roswell Park Cancer Institute 2009-04-30
NCT00002963 Photodynamic Therapy in Treating Patients With Skin Cancer https://ClinicalTrials.gov/show/NCT00002963 Completed Roswell Park Cancer Institute 2007-06-30
NCT00002882 Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma https://ClinicalTrials.gov/show/NCT00002882 Completed M.D. Anderson Cancer Center 2003-08-31
NCT00044356 Phase II Trial of Allovectin-7® for Metastatic Melanoma https://ClinicalTrials.gov/show/NCT00044356 Completed Vical 2004-08-31
NCT00007631 Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer https://ClinicalTrials.gov/show/NCT00007631 Completed VA Office of Research and Development 2004-11-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03370861 How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes https://ClinicalTrials.gov/show/NCT03370861 Recruiting Washington University School of Medicine 2022-12-31
NCT03822988 ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS https://ClinicalTrials.gov/show/NCT03822988 Recruiting Central Hospital, Nancy, France 2019-06-20
NCT03290989 Itch and Pain Characteristics in Skin Carcinomas https://ClinicalTrials.gov/show/NCT03290989 Completed University Hospital, Brest 2015-04-01
NCT03145506 Spectrally Guided Mohs Surgery https://ClinicalTrials.gov/show/NCT03145506 Completed Seton Healthcare Family 2016-12-31
NCT03122366 TLR4 Polymorphisms and Risk of Skin Cancer https://ClinicalTrials.gov/show/NCT03122366 Active, not recruiting University of Alabama at Birmingham 2011-09-27
NCT03092830 Molecular Characterization of Cutaneous Tumors https://ClinicalTrials.gov/show/NCT03092830 Recruiting Rabin Medical Center 2020-08-07
NCT03040492 Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk https://ClinicalTrials.gov/show/NCT03040492 Active, not recruiting University of Alabama at Birmingham 2015-05-01
NCT02704039 Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin https://ClinicalTrials.gov/show/NCT02704039 Completed University of Texas at Austin 2017-08-31
NCT02583815 Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) https://ClinicalTrials.gov/show/NCT02583815 Completed University of Texas Southwestern Medical Center 2017-09-15
NCT00046189 Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum https://ClinicalTrials.gov/show/NCT00046189 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02395562 Viral Reactivation and Skin Cancer https://ClinicalTrials.gov/show/NCT02395562 Completed University of Zurich 2016-01-31
NCT02244749 Role of Metabolic Enzymes in Non-Melanoma Skin Cancer https://ClinicalTrials.gov/show/NCT02244749 Completed University of California, Irvine 2015-08-31
NCT02235116 Predictors of Patient Attitudes and Barriers to Skin Cancer Screening https://ClinicalTrials.gov/show/NCT02235116 Completed Jonsson Comprehensive Cancer Center 2011-07-31
NCT02177006 Helping Children be Safe Outdoors With Sun Protection https://ClinicalTrials.gov/show/NCT02177006 Completed Northwestern University 2014-09-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01632644 Identifying Skin Biopsy Sites https://ClinicalTrials.gov/show/NCT01632644 Completed Northwestern University 2013-05-31
NCT01535963 Patient Satisfaction in Cutaneous Surgery https://ClinicalTrials.gov/show/NCT01535963 Active, not recruiting Northwestern University 2020-12-31
NCT01482260 Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma https://ClinicalTrials.gov/show/NCT01482260 Completed Ruhr University of Bochum 2012-01-31
NCT01480219 Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g https://ClinicalTrials.gov/show/NCT01480219 Completed Pfizer 2012-03-31
NCT01452984 Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project https://ClinicalTrials.gov/show/NCT01452984 Completed Abramson Cancer Center of the University of Pennsylvania 2013-12-31
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) https://ClinicalTrials.gov/show/NCT01447199 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT01418326 Cancer Mortality Affected by the Choice of Anesthetic Drugs? https://ClinicalTrials.gov/show/NCT01418326 Completed Uppsala University 2011-09-30
NCT01349894 SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs) https://ClinicalTrials.gov/show/NCT01349894 Completed KCI USA, Inc. 2012-06-30
NCT01345760 Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer https://ClinicalTrials.gov/show/NCT01345760 Completed Ruhr University of Bochum 2011-02-28
NCT04354064 Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors https://ClinicalTrials.gov/show/NCT04354064 Recruiting Washington University School of Medicine 2025-12-31
NCT04334824 Hydrochlorothiazide and Risk of Skin Cancer https://ClinicalTrials.gov/show/NCT04334824 Active, not recruiting Canadian Network for Observational Drug Effect Studies, CNODES 2021-06-30
NCT04267861 M7824 Related Adverse Effects in Adults With Cancer https://ClinicalTrials.gov/show/NCT04267861 Active, not recruiting National Institutes of Health Clinical Center (CC) 2021-11-01
NCT04164550 Interpolated Flap Study https://ClinicalTrials.gov/show/NCT04164550 Recruiting University of Pennsylvania 2020-04-30
NCT04123678 DERM Health Economics Study https://ClinicalTrials.gov/show/NCT04123678 Recruiting Skin Analytics Limited 2020-07-31
NCT04067960 Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer https://ClinicalTrials.gov/show/NCT04067960 Recruiting Mayo Clinic 2020-12-31
NCT04047316 Development and Validation of a New Digital Dermatoscope in the United States https://ClinicalTrials.gov/show/NCT04047316 Completed Barco NV 2020-04-15
NCT04015453 Correlation of Early Postoperative Scar Appearance With Long-term Scar Outcomes https://ClinicalTrials.gov/show/NCT04015453 Completed Abramson Cancer Center of the University of Pennsylvania 2016-11-30
NCT03818620 Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer https://ClinicalTrials.gov/show/NCT03818620 Recruiting Barco NV 2020-12-31
NCT03782727 ObservAtional Study to Investigate Surgical Site Infection in Ulcerated Skin Cancers https://ClinicalTrials.gov/show/NCT03782727 Completed Cardiff and Vale University Health Board 2020-05-31
NCT03693937 A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC) https://ClinicalTrials.gov/show/NCT03693937 Completed Sensus Healthcare 2019-03-16
NCT03497455 Utility of Digital Dermoscopy in the Skin Cancer Clinic https://ClinicalTrials.gov/show/NCT03497455 Active, not recruiting Barco NV 2020-12-31
NCT01259037 A Study of Ultrasonography With Elastography in Skin Neoplasms https://ClinicalTrials.gov/show/NCT01259037 Completed Wayne State University 2011-06-30
NCT00849914 Expression Levels of microRNA Processing Enzymes Dicer and Drosha in Epithelial Skin Cancer https://ClinicalTrials.gov/show/NCT00849914 Completed Ruhr University of Bochum 2009-02-28
NCT00824174 Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00824174 Completed M.D. Anderson Cancer Center 2012-09-30
NCT03503240 Patient Satisfaction With Facial Appearance and Scar Outcome After Skin Cancer Surgery https://ClinicalTrials.gov/show/NCT03503240 Enrolling by invitation Memorial Sloan Kettering Cancer Center 2021-04-30
NCT02941900 Interest and Impact of Skin Cancer Genetic Testing https://ClinicalTrials.gov/show/NCT02941900 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT00710489 Potential Research Study Participant Registry https://ClinicalTrials.gov/show/NCT00710489 Completed University of California, Davis 2018-09-05
NCT00633516 A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions https://ClinicalTrials.gov/show/NCT00633516 Completed University of California, Irvine 2013-11-30
NCT00597961 Health Communication in Families https://ClinicalTrials.gov/show/NCT00597961 Completed Memorial Sloan Kettering Cancer Center 2020-04-14
NCT00591500 A Model for Genetic Susceptibility: Melanoma https://ClinicalTrials.gov/show/NCT00591500 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT00588315 In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin https://ClinicalTrials.gov/show/NCT00588315 Recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT00555633 Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients https://ClinicalTrials.gov/show/NCT00555633 Completed Medical University of Graz NA
NCT00526032 Melanoma Detection by Oblique-Incidence Optical Spectroscopy https://ClinicalTrials.gov/show/NCT00526032 Completed M.D. Anderson Cancer Center 2012-01-31
NCT00518037 Quality of Life in Patients With Nonmelanoma Skin Cancer https://ClinicalTrials.gov/show/NCT00518037 Completed Northwestern University 2006-10-31
NCT00476905 Spectral Diagnosis of Cutaneous Malignancy https://ClinicalTrials.gov/show/NCT00476905 Completed M.D. Anderson Cancer Center 2018-11-20
NCT00342407 The Incidence of Breast and Other Cancers Among Female Flight Attendants https://ClinicalTrials.gov/show/NCT00342407 Completed National Institutes of Health Clinical Center (CC) 2005-12-31
NCT00099112 Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II https://ClinicalTrials.gov/show/NCT00099112 Completed National Cancer Institute (NCI) NA
NCT00836342 Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer https://ClinicalTrials.gov/show/NCT00836342 Completed Massachusetts General Hospital 2012-01-31
NCT00001813 Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy https://ClinicalTrials.gov/show/NCT00001813 Recruiting National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03301493 Genomic Testing and Resulting Medical Decisions https://ClinicalTrials.gov/show/NCT03301493 Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie 2019-12-31
NCT03253666 Nurses’ Health Study and Health Professionals Follow-Up Study (Dermatological Component) https://ClinicalTrials.gov/show/NCT03253666 Enrolling by invitation Harvard School of Public Health 2020-12-31
NCT02361229 Skin Cancer in Swiss Transplant Cohort Study https://ClinicalTrials.gov/show/NCT02361229 Active, not recruiting University of Zurich 2017-12-31
NCT02355587 Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes https://ClinicalTrials.gov/show/NCT02355587 Active, not recruiting Castle Biosciences Incorporated 2024-02-29
NCT02310503 Spanish Registry of Mohs Surgery https://ClinicalTrials.gov/show/NCT02310503 Completed Fundación Academia Española de Dermatología 2020-02-29
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://ClinicalTrials.gov/show/NCT03452774 Recruiting Massive Bio, Inc. 2021-12-31